1. Opening Hook
When steel prices tanked to a 5-year low, most players cried foul. Sarthak Metals just shrugged and said, “We’ll make biotech happen.” That’s like a foundry deciding to go pharma — but hey, diversification is the new defence. The quarter wasn’t a blockbuster, but between welding wires and ethanol enzymes, Sarthak seems to be melting iron and reinventing itself. Stick around, because by the time you finish reading, you might actually believe a steel alloy company can go bio.
2. At a Glance
- Cored Wire Volumes ↓14% YoY – Market got hammered harder than the steel it serves.
- Welding Division 🔥 – Now over 100 tons/month; finally something welding investor optimism together.
- Aluminium Coil Segment – Still in timeout; “unethical competition” blamed (the polite version of “price war”).
- Debt – Virtually nil. CFO can actually sleep at night.
- Biotech Venture – Not just talk; revenue “very soon” – the corporate equivalent of “trust the process.”
3. Management’s Key Commentary
“Our internal transformation is providing stability and optimism.”
(Translation: Steel’s crashing, but we’ve got backup plans and good vibes.)
“India has become a target market for cheap Asian imports.”
(Translation: Global steel dumping party, and we weren’t even invited. 😒)
“We stepped back from aluminium flipping coils due to unethical competition.”
(Translation: Someone’s selling below cost, and we’re too ethical—or broke—to follow.)
“Welding business achieved 100 tons monthly volumes.”
(Translation: Finally, a division where the numbers spark joy.)
“Biotech is gaining traction; discussions with ethanol distilleries ongoing.”
(Translation: Still no revenue, but at least the coffee meetings are promising.)
“We are virtually debt-free.”
(Translation: We can afford patience while everyone else panics.)
“Sustainability is key — our 400KW solar plant is just the start.”
(Translation: The green pitch is shining brighter than profits right now. 🌞)
